683 Capital Management’s Neuronetics STIM Stock Holding History

683 Capital Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,157	Closed	-$81.9K	–	242
2023 Q1	$81.9K	Buy	+28,157	New	+$142K	0.01%	231
2021 Q1	–	Sell	-24,713	Closed	-$275K	–	225
2020 Q4	$275K	Buy	+24,713	New	+$186K	0.01%	188

Other funds holding STIM

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

683 Capital Management's STIM Position: Q2 2023 in Review

683 Capital Management sold out of Neuronetics (STIM) in Q2 2023, closing a stake of 28,157 shares — an estimated $81.9K sold.

683 Capital Management first reported a position in STIM in Q4 2020 and held it in 2 quarters. The position peaked at $275K in Q4 2020. 69 funds tracked by Wall St. Rank hold STIM as of Q2 2023.

683 Capital Management reported no remaining Neuronetics position as of Q2 2023 after selling out during the quarter.
683 Capital Management sold 28,157 Neuronetics shares in Q2 2023, an estimated $81.9K.
683 Capital Management first reported a position in Neuronetics in Q4 2020 and held it in 2 quarters.
683 Capital Management's Neuronetics position peaked at $275K in Q4 2020.
69 funds tracked by Wall St. Rank held Neuronetics as of Q2 2023.

Based on 683 Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.